CXCL10 and neoplasm: Therefore, we proposed and investigated whether LL/2 presented “cold tumor” characteristics, and CT26 presented “hot tumor” characteristics with differential IFNα and CXCL10 levels to determine the immunotherapeutic efficacy in this study.